Twin Tree Management, LP Nuvalent, Inc. Transaction History
Twin Tree Management, LP
- $54.5 Billion
- Q4 2024
A detailed history of Twin Tree Management, LP transactions in Nuvalent, Inc. stock. As of the latest transaction made, Twin Tree Management, LP holds 140,100 shares of NUVL stock, worth $11.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
140,100
Previous 10,300
1260.19%
Holding current value
$11.3 Million
Previous $1.05 Million
941.5%
% of portfolio
0.02%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NUVL
# of Institutions
220Shares Held
61MCall Options Held
603KPut Options Held
769K-
Deerfield Management Company, L.P. (Series C) New York, NY20MShares$1.62 Billion38.02% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5MShares$405 Million18.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$364 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$245 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.98MShares$241 Million7.96% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.48B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...